Ahmed Mohamed Elshal

Ahmed Mohamed Elshal

Auto-generated profile, based on publicly available information

Ahmed Mohamed Elshal

Urology and Nephrology Center, Mansoura University, Mansoura, Egypt

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in European Urology Focus
Verified
Journal Article
Closed access
AHAbdelwahab Hashem
Abdelwahab Hashem
AMAhmed Mosbah
Ahmed Mosbah
NENasr A. El-Tabey
Nasr A. El-Tabey
MLMahmoud Laymon
Mahmoud Laymon
EIEl-Houssieny Ibrahiem
El-Houssieny Ibrahiem
AEAhmed M. Elshal
Ahmed M. Elshal

1 April 2017 in Journal of Urology
Verified
Journal Article
Closed access
AEAhmed M. Elshal
Ahmed M. Elshal
HNHossam Nabeeh
Hossam Nabeeh
YEYasser Eldemerdash
Yasser Eldemerdash
RMRamy Mekkawy
Ramy Mekkawy
MLMahmoud Laymon
Mahmoud Laymon
AEAhmed R. El-Nahas
Ahmed R. El-Nahas
Despite being endorsed in most guidelines, wide adoption of holmium laser enucleation of the prostate is hindered by learning difficulties. We prospectively assessed the learning curve using a multidimensional approach. We prospectively report all perioperative safety and efficacy outcome measures as well as the need for reoperation and continence status. Case difficulty and learning curve characterization variables were considered, looking for predictors of different outcome measures. Our analysis included the first 313 procedures done by a total of 3 surgeons. Prostate volume and the number of previously performed cases independently predicted operative and enucleation efficiency (mean ± SD 0.76 ± 0.36 and 1.2 ± 0.6 gm per minute, respectively). Both measures plateaued only after the first 40 procedures. The mean percent reduction in postoperative prostate specific antigen was 80% ± 19%. A significantly lower decrease was independently predicted by the transrectal ultrasound depiction of a grossly multinodular prostate (p = 0.000, R2 = 0.59). Perioperative safety measures showed significant improvement after the first and second 20 procedures apart from hospital stay and catheter time. Urinary incontinence was reported in 89 (28.5%), 26 (8.3%) and 7 cases (2.2%) at 1, 4 and 12 months, respectively. Only the number of previously performed cases predicted urinary incontinence at 1 month, which was significantly reduced following the first 20 procedures (plateau) (OR 0.99, 95% CI 0.98-0.999, p = 0.03). The I-PSS (International Prostate Symptom Score) preoperative storage subdomain (OR 0.7, 95% CI 0.4-0.9, p = 0.04), case density (OR 0.3, 95% CI 0.2-0.6, p = 0.01) and number of previously performed cases (OR 0.97, 95% CI 0.98-0.999, p = 0.02) predicted urinary incontinence at 4 months, which was significantly reduced after the first and second 20 procedures. Persistent urinary incontinence at 12 months was significantly associated with fewer previously performed cases (median 60, range 0 to 211 vs 20, range 0 to 99, p = 0.04) with no plateauing through the curve. Plateauing through the learning curve of holmium laser enucleation of the prostate is a moving target. Looking at different outcome measures, different levels of experience are needed to reach the plateau. Preoperative prostate volume, the number of previously performed cases and case density are the main influential factors in the curve. Urinary incontinence is the most relevant clinical outcome that was significantly affected by learning, although its transient nature is assuring.

6 July 2020 in BJU International
Verified
Journal Article
Closed access
PDF file
AEAhmed M. Elshal
Ahmed M. Elshal
MSMohamed Soltan
Mohamed Soltan
NENasr A. El‐Tabey
Nasr A. El‐Tabey
MLMahmoud Laymon
Mahmoud Laymon
ANAdel Nabeeh
Adel Nabeeh

1 November 2018 in Urology
Verified
Journal Article
Closed access
AEAhmed M. Elshal
Ahmed M. Elshal
AEAhmed R. El-Nahas
Ahmed R. El-Nahas
MGMostafa Ghazy
Mostafa Ghazy
HNHossam Nabeeh
Hossam Nabeeh
MLMahmoud Laymon
Mahmoud Laymon
HEHamdy A. El-Kappany
Hamdy A. El-Kappany

1 December 2013 in Arab Journal of Urology
Verified
Journal Article
Open access
AEAhmed M. Elshal
Ahmed M. Elshal
AEAhmed R. El-Nahas
Ahmed R. El-Nahas
TBTamer S. Barakat
Tamer S. Barakat
MEMohamed M. Elsaadany
Mohamed M. Elsaadany
AEAhmed S. El-Hefnawy
Ahmed S. El-Hefnawy
To assess the perioperative morbidity of transvesical open prostatectomy (OP) and its predictors as a treatment for benign prostatic hyperplasia (BPH), and to update knowledge about the morbidity of OP using a standardised morbidity scale (Clavien), thus providing a platform for comparison with the newly developed techniques. We retrospectively review men with BPH who were treated with transvesical OP between April 2002 and December 2012. Preoperative patients' data were reviewed for relevant variables. Operative details, the postoperative course, and 30-day relevant data were assessed. The study cohort was stratified based on the resected prostate weight, with group 1 having a resected weight of ⩽120 g and group 2 >120 g. The review identified 163 patients. The mean (SD, range) duration of catheterisation after OP was 7.9 (2.2, 5-20) days and the duration of hospitalisation after OP was 8.1 (1.8, 5-15) days; both were significantly longer in group 2. All patients were able to void spontaneously by the first follow-up visit. Of 163 OP procedures, there were 106 perioperative complications in 69 (42.3%). Low-grade complications (grade ⩽2) included 38 (45.2%) and 53 (67%) in groups 1 and 2, respectively (P = 0.8). High-grade complications (⩾3) included 3 (3.5%) and 12 (15.1%) in groups 1 and 2, respectively (P = 0.02). The blood transfusion rate was 24.5%, the perioperative mortality rate was 1.2% and the re-admission rate within the first 30 days after OP was 1.2%. High-grade complications were significantly associated with a greater resected prostate weight (odds ratio 1.08, 95% CI 1.001-1.17, P = 0.046). The OP procedure is associated with a significant perioperative morbidity that correlated significantly with the resected prostate weight, especially for high-grade complications.

9 September 2015 in Canadian Urological Association Journal
Verified
Journal Article
Closed access
PDF file
AEAhmed M. Elshal
Ahmed M. Elshal
RMRamy Mekkawy
Ramy Mekkawy
MLMahmoud Laymon
Mahmoud Laymon
AEAhmed El-Assmy
Ahmed El-Assmy
AEAhmed R. El-Nahas
Ahmed R. El-Nahas
Introduction: We assess different approaches to retrieve the enucleated adenoma after transurethral enucleation of the prostate, particularly using the holmium laser.Methods: A retrospective review through our prospectively maintained database was performed looking for safety and efficacy of two morcellators. The enucleation phase of the holmium laser enucleation of the prostate (HoLEP) was classically performed followed by retrieval of the intravesical adenoma using either the Piranha (Wolf Inc., Knittlingen, Germany) or VersaCut (Lumenis) morcellator. A PubMed-MEDLINE search was conducted for all transurethral enucleation procedures and relevant data regarding methods of prostate tissue retrieval were extracted.Results: Strictly limiting the study to 3 reusable blades with each morcellator, we performed 67 and 55 consecutive procedures with Piranha and VersaCut, respectively. There was no significant difference between the two morcellators regarding perioperative complications, apart from 5 bladder mucosal injuries with the VersaCut (9%). Furthermore, there were similar retrieved tissue weight, mechanical problems-rate, catheter-time and hospital-stay in both morcellators. However, the Piranha morcellator needed significantly less morcellation-time, needed to use cold loop to remove non-morcellated pieces and to score the adenoma by laser for better bite of the adenoma, and had a higher median morcellation-rate 6.2 (rate: 2.8–12) g/min. Despite little reporting on morcellation, we had data on the tissue retrieval rate (2.6 to 6.5 g/min with Piranha and 1.9 to 11 g/min with VersaCut. Furthermore, bladder mucosal injury was reported in 1.4% and 0.7 to 5.7% with Piranha and VersaCut, respectively; bladder perforation with VersaCut was experienced in about 0.1 to 1.5% of patients. Our study is limited by its non-randomization.Conclusion: The Piranha morcellator was the most efficient and safe way to retrieve tissue after a transurethral enucleation of a prostate adenoma.